Jonathan I Epstein (Jonathan Epstein)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 19

Top Topics

Radical Prostatectomy

Prostate Cancer

Top Venues

BJU international

International journal of surgical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Laurence M Briski, Manju Aron, Jonathan I Epstein, Daniel Hugh Russell, Naziheh Assarzadegan, Katiana S Delma, Henry O'Dell, Estelamari Rodriguez, Elizabeth A Montgomery, Oleksandr N Kryvenko
Patterns of Immunoreactivity with TTF-1 Antibodies 8G7G3/1 and SPT24 Suggest Distinct Immunoprofiles Between Most Pulmonary and Nonpulmonary Small Cell Carcinomas. International journal of surgical pathology (2023)
Sonia Kamanda, Lourdes Huanca-Amesquita, Esperanza Milla, Pedram Argani, Jonathan I Epstein
Clinicopathologic Classification of Renal Cell Carcinoma in Patients ≤40 Years Old From Peru. International journal of surgical pathology (2023)
Jianping Zhao, Jonathan I Epstein
Significance of extraprostatic extension by Grade Groups 1-3 prostatic carcinoma on needle biopsy. The Prostate (2023)
Katrina M Collins, Lynette M Sholl, Stephanie Siegmund, Brendan C Dickson, Maurizio Colecchia, Květoslava Michalová, Michael Hwang, Thomas M Ulbright, Chia-Sui Kao, G J L H Geert van Leenders, Vikas Mehta, Kiril Trpkov, Asli Yilmaz, Alessia Cimadamore, Andres Matoso, Jonathan I Epstein, Fiona Maclean, Eva M Comperat, William J Anderson, Christopher D M Fletcher, Andres Martin Acosta
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional series. Histopathology (2022)
Jonathan I Epstein, Adam S Kibel
Renaming Gleason Score 6 Prostate to Noncancer: A Flawed Idea Scientifically and for Patient Care. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Andres Martin Acosta, Ankur R Sangoi, Fiona Maclean, Kiril Trpkov, Adeboye O Osunkoya, Katrina M Collins, Hiroshi Miyamoto, Michelle S Hirsch, Emily Chan, Maria S Tretiakova, Sambit K Mohanty, Seema Kaushal, Kristine M Cornejo, Manju Aron, Gabriela M Quiroga-Garza, Kanika Arora, Jane K Nguyen, Sean R Williamson, Jonathan I Epstein, Andres Matoso
Prostatic malakoplakia: clinicopathological assessment of a multi-institutional series of 49 patients. Histopathology 81 (4) (2022)
Jonathan I Epstein
Very low-risk versus low-risk prostate cancer: A distinction worth keeping. The Prostate 81 (13) (2021)
Harsimar B Kaur, Daniela C Salles, Adina Paulk, Jonathan I Epstein, James R Eshleman, Tamara L Lotan
PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations. Histopathology 78 (2) (2020)
Jonathan I Epstein
Intraductal carcinoma of the prostate does not always represent invasive high-grade carcinoma extending into ducts. Histopathology 78 (2) (2020)
Mufaddal K Mamawala, Alexa R Meyer, Patricia K Landis, Katarzyna J Macura, Jonathan I Epstein, Alan W Partin, Ballentine H Carter, Michael A Gorin
Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance. BJU international 125 (6) (2020)
Murali Varma, Jonathan I Epstein
Head to head: should the intraductal component of invasive prostate cancer be graded? Histopathology 78 (2) (2020)
Zeyad R Schwen, Mufaddal K Mamawala, Jeffrey J Tosoian, Sasha C Druskin, Ashley E Ross, Lori J Sokoll, Jonathan I Epstein, Herbert Ballentine Carter, Michael A Gorin, Christian P Pavlovich
Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance. BJU international 126 (3) (2020)
David J Epstein, Lester D R Thompson, Atif Saleem, Chia-Sui Kao, Jonathan I Epstein
Fungal prostatitis due to endemic mycoses and Cryptococcus: A multicenter case series. The Prostate 80 (12) (2020)
Andres Matoso, Jonathan I Epstein
Defining clinically significant prostate cancer on the basis of pathological findings. Histopathology 74 (1) (2019)
Tamara L Lotan, Harsimar B Kaur, Abdullah M Alharbi, Colin C Pritchard, Jonathan I Epstein
DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant-cell features. Histopathology 74 (6) (2019)
Antonio L Cubilla, Elsa F Velazquez, Mahul B Amin, Jonathan I Epstein, Daniel M Berney, Cathy M Corbishley, null null
The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations. Histopathology 72 (6) (2018)
Alba Torres, Mohammed Alshalalfa, Elai Davicioni, Anuj Gupta, Srinivasan Yegnasubramanian, Sarah J Wheelan, Jonathan I Epstein, Angelo M De Marzo, Tamara L Lotan
ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63. The Prostate 78 (12) (2018)
Evita T Sadimin, Ying-Bei Chen, Lu Wang, Pedram Argani, Jonathan I Epstein
Chromosomal abnormalities of high-grade mucinous tubular and spindle cell carcinoma of the kidney. Histopathology 71 (5) (2017)
Yunjie Li, Victor E Reuter, Andres Matoso, George J Netto, Jonathan I Epstein, Pedram Argani
Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients. Histopathology 72 (4) (2017)